Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q1 2025 · 10-Q
Revenue$7.97M$7.97M+1.5% vs Q1 2024 Net Income$282.86K$282.86K−49.1% vs Q1 2024 EPS Diluted$0.03$0.03−57.1% vs Q1 2024 Operating Income$1,056,011+28.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
Free Cash Flowderived$892,010N/M Margins · derivedOperating margin13.3%+2.8 pt vs Q1 2024
Net margin3.5%−3.5 pt vs Q1 2024
ended Feb 28, 2025 · filed Apr 14, 2025 · 45 d after period end